---
title: 'Cell Therapy Account Management - North Texas at Iovance Biotherapeutics'
canonical: 'https://feeny.ai/job/cell-therapy-account-management-north-texas-iovance-biotherapeutics-dallas-k5mzq46k4c1j'
type: 'job'
last_seen: '2026-09-17'
---

# Cell Therapy Account Management - North Texas at Iovance Biotherapeutics

- **Company:** Iovance Biotherapeutics
- **Location:** Dallas, TX
- **Compensation:** $200k–$220k
- **Work type:** remote
- **Posted:** 2026-09-14
- **Last confirmed live:** 2026-09-17
- **Apply:** https://job-boards.greenhouse.io/iovancebiotherapeutics/jobs/5423655008

## Job description

Iovance Biotherapeutics aims to be the global leader in innovating, developing and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. We are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, which may be a promising option for patients with cancer.

## Overview

Amtagvi™ is the best-in-class cell therapy treatment for advanced melanoma. The Cell Therapy Account Management (CTAM) will be responsible for driving Amtagvi demand by building a robust referral network between community practices and academic centers; enable early patient identification and streamline referral pathways; and collaborate with internal teams to enhance scientific and operational excellence in cell therapy account management.

To succeed in this role, you will use prior experience to optimize territory strategy in the oncology rare disease space and have demonstrated experience influencing others and building relationships. Additional competencies include experience with immunotherapy and solid tumor cancer, as well as prior launch experience, demonstrated ability to drive demand, pull through, and sustain the growth of Amtagvi™.

Essential Functions and Responsibilities:

- Drive AmtagviTM demand and appropriate pull-through at targeted ATCs and serve as a liaison between community oncology practices and internal stakeholders to align initiatives with business and medical objectives.
- Serve as the primary commercial point of contact for the Iovance iPOD at authorized treatment centers offering commercially available AmtagviTM. Serve as the commercial lead for developing and onboarding a new TIL service line at target ATCs.
- Educate site personnel on clinical and product information for AmtagviTM.
- Provide knowledge and expertise around Iovance products and processes to all service line customer stakeholders.
- Collaborate with ATC Operations, aligning Iovance Cell Therapy logistics, processes, and operations.
- Provide exemplary customer service while building business relationships with key clinical thought leaders, AmtagviTM prescribers, and other institutional stakeholders to influence the uptake of AmtagviTM.
- Develop and maintain applicable disease state, product-specific (AmtagviTM), and competitive landscape knowledge.
- Attend and support professional meetings and congresses regionally and nationally.
- Facilitate engagement with key thought leaders, Cell Therapy prescribers, and other institutional stakeholders.
- Maintain a high level of collaboration and communication with Iovance cross-functional partners in Market Access, Operations, Quality, Marketing, Medical, and others to ensure appropriate patient identification, infusion of AmtagviTM, and clinical care related to AmtagviTM.
- Facilitate and provide timely feedback to appropriate Iovance management regarding account business trends, changes in the therapeutic landscape, industry issues, and business opportunities.
- Collaborate with the sales leadership team to develop and implement strategic account plans in qualified academic institutions and large community medical oncology practices.
- Maintain compliance with US/global healthcare laws and regulations.
- Exemplify Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.
- Perform miscellaneous duties as assigned.

Travel – 50%

Required Education, Skills, and Knowledge:

- 8-12 years of related experience with a bachelor’s degree; or 6 years and a master’s degree; or a PhD with 3 years’ experience; or equivalent experience in a similar role within oncology/cell therapy or rare disease. Some barriers to entry exist at this level, requiring department review.
- Uses strategic foresight to optimize strategy and build service lines at academic hospitals
- Demonstrates deep market knowledge of the oncology and immunotherapy market, including reimbursement and policy landscape within academic hospitals, oncology clinics, and extensive community practices.
- Prior experience of products and therapies requiring complex delivery systems, including logistics management and regulatory and compliance requirements (i.e., GMP, Quality systems),
- Ability to coach and drive alignment with field-based and internal cross-functional partners.
- Uses data analytics to optimize decision-making and planning around Amtagvi’s uptake strategy.
- Demonstrate initiative, high sense of urgency, and perseverance in a fast-paced, entrepreneurial environment.
- Must have a valid driver's license.

Preferred Education, Skills, and Knowledge

- Oncology/cell therapy or rare disease experience preferred.
- MBA or other related graduate-level degree is preferred.
- New product launch experience
- Experience in oncology care, new product launches, and cell therapy is preferred.

Physical Demands and Activities Required

- Must be able to remain in a stationary position, standing or sitting for prolonged periods of time.
- Must be able to move about inside an office and exert up to 10 pounds of force occasionally or a negligible amount of force frequently or constantly to lift, carry, push, pull, or otherwise move objects.
- Must have visual acuity to prepare and analyze data and figures, view a computer screen, and read extensively.
- This position requires repetitive motion, substantial movements (motions) of the wrist, hands, and/or fingers.
- Must be able to communicate with others to exchange information.

Mental: Clear and conceptual thinking ability; excellent judgment, troubleshooting, problem-solving, analysis, and discretion; ability to handle work-related stress; ability to handle multiple priorities simultaneously; and ability to meet deadlines

Work Environment

This job operates in a professional or remote office environment and requires operating standard office equipment and keyboards.

#li-remote The annual base salary we reasonably expect to pay is listed. Individual pay decisions depend on various factors, such as primary work location, complexity and responsibility of the role, job duties/requirements, and relevant education, experience and skills.

Pay Transparency $200,000—$220,000 USD

The statements contained in this document are intended to describe the general nature and level of work being performed by a colleague assigned to this description. They are not intended to constitute a comprehensive list of functions, duties, or local variances. Management retains the discretion to add or to change the duties of the position at any time.

Iovance is committed to cultivating and offering a diverse and inclusive work environment. As an equal-opportunity employer, our employees and applicants will be considered without regard to an individual’s race, color, religion, sex, pregnancy, national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information, military and veteran status, and any other characteristic protected by applicable law. If you need assistance or accommodation to apply to one of our opportunities, please contact careers@iovance.com.

By voluntarily providing information and clicking “Submit Application”, you explicitly consent to the collection and use of your personal information for the purposes described above and in our [Candidate Privacy Notice](https://www.iovance.com/privacy-policy/).

## About Iovance Biotherapeutics

## Company Overview
- **One-liner**: Iovance Biotherapeutics is pioneering tumor infiltrating lymphocyte (TIL) cell therapies to develop personalized, one-time treatments for solid tumor cancers.
- **Entity Type**: Public (NASDAQ: IOVA)
- **Headquarters**: San Carlos, California, USA
- **Founded**: 2007 (originally named Lion Biotechnologies, renamed Iovance Biotherapeutics in 2017)
- **Founders**: Not publicly available (the company was formed through a merger and rebranding)

## Core Business
- **Primary industry**: Biotechnology — Cell Therapy (Immuno-Oncology)
- **Target customers**: B2B / B2G — Healthcare providers, clinical trial sites, and ultimately patients with advanced solid tumors (melanoma, non-small cell lung cancer, endometrial cancer, etc.)
- **Mission or purpose statement**: To be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer, harnessing the immune system to recognize and attack diverse cancer cells.

## Products & Services
- **Lifileucel (IOV-009)**: A one-time, personalized TIL therapy for advanced melanoma. It is the first approved TIL therapy for a solid tumor (FDA approved in early 2024 under the brand name Amtagvi).
- **IOV-LUN-202**: An investigational TIL therapy for advanced non-small cell lung cancer (NSCLC) currently in Phase 2 clinical trials.
- **IOV-END-201**: An investigational TIL therapy for advanced endometrial cancer currently in Phase 2 clinical trials.
- **IOV-4001**: A next-generation, gene-edited TIL therapy (using TALEN technology to inactivate PD-1 expression) for solid tumors, currently in preclinical/early clinical development.
- **IOV-3001**: An engineered IL-2 therapy (licensed from Novartis) designed to support TIL therapy efficacy, currently in preclinical development.
- **Cell Therapy Manufacturing (iCTC)**: The company operates a 136,000-square-foot, state-of-the-art Cell Therapy Center in Philadelphia, PA, for proprietary GMP manufacturing of TIL therapies.

## Market Standing
- **Valuation/Market Cap**: As of early 2026, market capitalization is approximately $2.5–3.0 billion (fluctuates with FDA news and clinical data). Check current price on NASDAQ: IOVA.
- **Key Metric (Revenue)**: Iovance generated its first commercial revenue from Lifileucel/Amtagvi in 2024. Annual revenue for 2025 was approximately $180–220 million (estimate based on analyst reports; exact figure not yet fully disclosed). The company is not yet profitable.
- **Key Metric (Funding)**: As a public company, Iovance has raised over $1.5 billion through public offerings and debt financings. Notable recent raise: a public offering in 2022 and subsequent at-the-market offerings.
- **Notable Investors/Partners**:
    - Novartis (license partner for IOV-3001)
    - Major institutional investors (e.g., BlackRock, Vanguard, and several healthcare-focused funds)
    - Collaborations with major cancer centers for clinical trials (e.g., MD Anderson, Memorial Sloan Kettering, etc.)
- **Growth Signals**:
    - FDA approval of Lifileucel (Amtagvi) in early 2024 — a landmark first-in-class approval for TIL therapy in solid tumors.
    - Rapid commercial launch and expansion of treatment centers across the U.S.
    - Multiple ongoing Phase 2/3 trials in large indications (NSCLC, endometrial cancer, frontline melanoma).
    - Investment in next-generation gene-edited TIL (IOV-4001) and engineered IL-2 (IOV-3001) to improve efficacy and expand addressable patient populations.

## Competitive Advantages
- **First-to-market TIL therapy**: Iovance is the only company with an FDA-approved TIL therapy for a solid tumor (Amtagvi for melanoma), giving it a significant head start in manufacturing, commercial infrastructure, and physician education.
- **Proprietary manufacturing platform**: The in-house iCTC facility in Philadelphia enables scalable, standardized GMP production of personalized TIL therapies, a major barrier to entry for competitors.
- **Broad solid tumor pipeline**: Unlike CAR-T therapies (primarily effective in blood cancers), TIL therapy has shown promise across multiple solid tumor types, providing a large addressable market.
- **Polyclonal T cell approach**: The therapy targets a broad range of neoantigens unique to each patient’s tumor, potentially reducing the risk of immune escape compared to single-target therapies.

## Strategic Focus
- **Commercial expansion**: Scaling up the launch of Amtagvi for advanced melanoma and expanding treatment center network globally.
- **Pipeline acceleration**: Advancing pivotal trials in NSCLC (IOV-LUN-202) and endometrial cancer (IOV-END-201) to secure additional FDA approvals.
- **Next-generation innovation**: Developing gene-edited TIL (IOV-4001) to enhance persistence and efficacy, and engineered IL-2 (IOV-3001) to improve the TIL therapy cycle.
- **Manufacturing optimization**: Continuing to improve manufacturing efficiency and turnaround time at the iCTC facility to support growing demand and reduce costs.

## Why Work Here
- **Mission-driven culture**: The company is deeply patient-centric, with a clear focus on delivering transformative therapies to cancer patients. Employees often cite the meaningful impact of their work as a key motivator.
- **Values**: Integrity, agility, innovation, collaboration, and excellence are core to the company’s operating philosophy. The culture emphasizes transparency, teamwork, and high ethical standards.
- **Diversity, Equity, and Inclusion**: Iovance has a stated commitment to DEI, recognizing that internal diversity is critical to serving diverse patient populations and driving innovation.
- **Remote/Hybrid policy**: Many roles (especially in clinical, medical affairs, marketing, and commercial functions) are remote or hybrid. Laboratory and manufacturing roles are based on-site in Philadelphia, PA (iCTC) or San Carlos, CA (HQ).
- **Benefits**: Competitive salaries, annual cash bonuses, long-term incentives (stock options/RSUs), 401(k) with match, Employee Stock Purchase Plan, comprehensive medical/dental/vision (low employee cost), Health Savings Account contributions, paid parental leave, tuition assistance, wellness program (gym discounts), and professional development opportunities.
- **Work environment**: Agile and fast-paced, typical of a biotech company at a critical growth stage. The company values data-driven decision-making and encourages employees to bring their best efforts every day.

## Sources
1. [iovance.com](https://www.iovance.com/)
2. [iovance.com - About Us](https://www.iovance.com/about-iovance-biotherapeutics/)
3. [iovance.com - Culture](https://www.iovance.com/culture/)
4. [job-boards.greenhouse.io](http://job-boards.greenhouse.io/iovancebiotherapeutics)

## Other roles at Iovance Biotherapeutics

- [Director, Clinical Operations](https://feeny.ai/job/director-clinical-operations-iovance-biotherapeutics-remote-kmc2mhrmcbxy)
- [Senior Manager, Protein Sciences Downstream](https://feeny.ai/job/senior-manager-protein-sciences-downstream-iovance-biotherapeutics-remote-e75xtwg2dw10)
- [Clinical QA Specialist II, Clinical Specialist Providers (CSP)](https://feeny.ai/job/clinical-qa-specialist-ii-clinical-specialist-providers-csp-iovance-0xvh3ekvwwfv)
- [Senior Manager, Technical Learning Center of Excellence](https://feeny.ai/job/senior-manager-technical-learning-center-of-excellence-iovance-biotherapeutics-bxz14ba1v5nd) — Philadelphia Pennsylvania, United States
- [Aseptic Manufacturing Technician I - Night Shift B [Contract to Hire]](https://feeny.ai/job/aseptic-manufacturing-technician-i-night-shift-b-contract-to-hire-iovance-npy381ja7k30) — Philadelphia, PA
- [Aseptic Manufacturing Technician I - Day Shift A [Contract to Hire]](https://feeny.ai/job/aseptic-manufacturing-technician-i-day-shift-a-contract-to-hire-iovance-4e92ffmwhpkr) — Philadelphia, PA
- [Production Planner](https://feeny.ai/job/production-planner-iovance-biotherapeutics-philadelphia-2jkyvc79mh98) — Philadelphia, PA
- [Lead Endpoint Engineering Architect](https://feeny.ai/job/lead-endpoint-engineering-architect-iovance-biotherapeutics-remote-7ska57zabwp5)
- [Associate Director, Digital Experience & AI Production](https://feeny.ai/job/associate-director-digital-experience-ai-production-iovance-biotherapeutics-6vpwzzkanpmb)
- [Aseptic Manufacturing Technician I - Day Shift A [Contract to Hire]](https://feeny.ai/job/aseptic-manufacturing-technician-i-day-shift-a-contract-to-hire-iovance-z7jk5970wezw) — Philadelphia, PA